Related Experiment Video

Updated: Mar 29, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.6K

A promising "TRAIL" of tanshinones for cancer therapy

Tsing-Fen Ho1, Chia-Che Chang2,3,4,5

  • 1Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, 406, Taichung, Taiwan.

Biomedicine
|December 2, 2015
PubMed

Insights

Tanshinones, derived from Salvia miltiorrhiza, enhance cancer cell death when combined with Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) therapy. This combination overcomes TRAIL resistance by modulating key apoptosis-related proteins.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • The development of targeted cancer therapies remains a critical challenge.
  • Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) shows promise for cancer treatment due to its selective induction of apoptosis in cancer cells.
  • However, clinical applications of TRAIL are hindered by intrinsic or acquired resistance in tumors.

Purpose of the Study:

  • To review the TRAIL-sensitizing effects of tanshinones, natural compounds from Salvia miltiorrhiza.
  • To explore the potential of tanshinones as adjuncts to TRAIL-based cancer therapies.

Main Methods:

  • Literature review focusing on studies investigating tanshinones and their interaction with TRAIL signaling pathways.
  • Analysis of research demonstrating the synergistic effects of tanshinones and TRAIL in various cancer cell types.
  • Examination of the molecular mechanisms underlying tanshinone-mediated sensitization, including receptor modulation and anti-apoptotic protein regulation.

Main Results:

  • Tanshinones, the active components of Salvia miltiorrhiza, exhibit significant TRAIL-sensitizing properties.
  • The combination of tanshinones with TRAIL effectively induces apoptosis in diverse cancer cell lines.
  • Sensitization is achieved through mechanisms such as up-regulation of death receptor 5 (DR5) and down-regulation of anti-apoptotic proteins like survivin.

Conclusions:

  • Tanshinones hold considerable potential as TRAIL sensitizers, offering a strategy to overcome TRAIL resistance in cancer.
  • The synergistic combination of tanshinones and TRAIL presents a promising avenue for developing novel, effective cancer therapeutics.
  • Further research and clinical translation of tanshinone-TRAIL combination therapies are warranted.
Keywords:
ApoptosisCancer therapyDanshenTRAILTanshinones

More Related Videos

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

791
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

3.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K